Equities

TruBridge Inc

TruBridge Inc

Actions
Health CareHealth Care Providers
  • Price (USD)16.93
  • Today's Change0.39 / 2.36%
  • Shares traded57.40k
  • 1 Year change+52.80%
  • Beta0.6433
Data delayed at least 15 minutes, as of Nov 25 2024 21:00 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year TruBridge Inc had net income fall from a gain of 15.87m to a loss of 45.79m despite a 3.91% increase in revenues from 326.65m to 339.44m. An increase in the selling, general and administrative costs as a percentage of sales from 25.13% to 30.70% was a component in the falling net income despite rising revenues.
Gross margin49.31%
Net profit margin-17.72%
Operating margin-12.76%
Return on assets-14.40%
Return on equity-29.08%
Return on investment-16.50%
More ▼

Cash flow in USDView more

In 2023, cash reserves at TruBridge Inc fell by 3.10m. Cash Flow from Financing totalled 55.95m or 16.48% of revenues. In addition the company generated 1.06m in cash from operations while cash used for investing totalled 60.11m.
Cash flow per share-2.11
Price/Cash flow per share--
Book value per share11.57
Tangible book value per share-8.09
More ▼

Balance sheet in USDView more

TruBridge Inc has a Debt to Total Capital ratio of 50.52%, a lower figure than the previous year's 60.86%.
Current ratio1.80
Quick ratio1.78
Total debt/total equity1.02
Total debt/total capital0.5052
More ▼

Growth rates in USD

Year on year, growth in earnings per share excluding extraordinary items dropped -391.16%.
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago
-7,466.12
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.